Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chingwei V Lee

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|April 15, 2025
Trop-2 expression in non-small cell lung cancerPeiwen Kuo, Emon Elboudwarej, Marianna Zavodovskaya, et al.
Plos One|May 8, 2012
Translation levels control multi-spanning membrane protein expressionHok Seon Kim, James A Ernst, Cecilia Brown, et al.
Science (New York, N.Y.)|March 21, 2009
Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding siteJenny Bostrom, Shang-Fan Yu, David Kan, et al.
The Journal of Biological Chemistry|November 10, 2005
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang, Xiumin Wu, Franklin V Peale, et al.
Blood|July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cellsChingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.
Investigative Ophthalmology & Visual Science|October 2, 2019
Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor OutflowEvan A Thackaberry, Yi Zhou, Christina L Zuch de Zafra, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesHans-Peter Gerber, Xiumin Wu, Lanlan Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Cancer Cell|October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodiesGabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|April 15, 2025
Trop-2 expression in non-small cell lung cancerPeiwen Kuo, Emon Elboudwarej, Marianna Zavodovskaya, et al.
Plos One|May 8, 2012
Translation levels control multi-spanning membrane protein expressionHok Seon Kim, James A Ernst, Cecilia Brown, et al.
Science (New York, N.Y.)|March 21, 2009
Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding siteJenny Bostrom, Shang-Fan Yu, David Kan, et al.
The Journal of Biological Chemistry|November 10, 2005
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang, Xiumin Wu, Franklin V Peale, et al.
Blood|July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cellsChingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.
Investigative Ophthalmology & Visual Science|October 2, 2019
Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor OutflowEvan A Thackaberry, Yi Zhou, Christina L Zuch de Zafra, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesHans-Peter Gerber, Xiumin Wu, Lanlan Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Cancer Cell|October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodiesGabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Pageof 3